REQUEST A DEMO
Total
USD $0.00
Search more companies

"Pfizer Trading Polska Sp. z o.o." (Poland)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: "Pfizer Trading Polska Sp. z o.o." Profile Updated: May 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Pfizer Trading Polska Sp. z o.o. is a subsidiary of Pfizer, an innovative biopharmaceutical company. With over 60 years of operation, the company has expanded its activities and is now one of the most innovative pharmaceutical companies in the country, employing over 500 people. While the main headquarters is located in Warsaw, Pfizer representatives are present in all major cities in Poland.

Headquarters
Ul. Zwirki I Wigury 16B
Warsaw; Mazowieckie; Postal Code: 02-092

Contact Details: Purchase the "Pfizer Trading Polska Sp. z o.o." report to view the information.

Website: https://www.pfizer.com.pl

Basic Information
Total Employees:
Purchase the "Pfizer Trading Polska Sp. z o.o." report to view the information.
Outstanding Shares:
Purchase the "Pfizer Trading Polska Sp. z o.o." report to view the information.
Registered Capital:
Purchase the "Pfizer Trading Polska Sp. z o.o." report to view the information.
Financial Auditors:
Purchase the "Pfizer Trading Polska Sp. z o.o." report to view the information.
Incorporation Date:
February 09, 2005
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after "Pfizer Trading Polska Sp. z o.o." report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
13.01%
Total operating revenue
13.04%
Operating profit (EBIT)
6.67%
EBITDA
6.67%
Net Profit (Loss) for the Period
15.65%
Total assets
14.34%
Total equity
14.63%
Operating Profit Margin (ROS)
-0.31%
Net Profit Margin
0.11%
Return on Equity (ROE)
0.11%
Quick Ratio
0.41%
Cash Ratio
0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?